Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

There are a handful of companies offering to clone pets. Viagen, which claims to have “cloned more animals than anyone else ...

We share the same disruptive DNA – reimagining the foundations of our industries to help others do the same,” Lumen CEO Kate Johnson said in a statement. “By bringing AI into real-world operations ...

Imunon is focusing TheraPlas on developing treatments for aggressive, hard-to-treat cancers, starting with ovarian. Its lead ...

Applied DNA Sciences ( ($BNBX) ) has shared an announcement. On November 4, 2025, Applied DNA Sciences entered into an At The Market Offering ...

Demonstrated feasibility of effective DNA delivery with Company's xPhore nanoparticle technologyDNA delivery technology to be offered as GenePhore to biotech / pharma companiesAddressing large and gro ...

Turkish immigrant Oguzhan Atay started the company in 2016 with a focus on prenatal testing. Now, he’s expanding to cancer ...

BillionToOne, Inc. develops DNA molecular counting technology. It can detect disorders such as sickle cell disease and cystic fibrosis. The company was founded by Oguzhan Atay, Sukrit Silas, and David ...

Agents that outsmart phishing attacks, digital DNA for photos and videos, a way for humans to prove they’re human, and more.

The 33-year-old man was “a professional organist who had recently married and moved to Ventura County,” deputies said.

Scilex Holding Company (“Scilex” or the “Company”) (Nasdaq: SCLX), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for ...